Is there a generic version of suvorexant yet?
Suvorexant (brand name Belsomra) does not appear to have broad, widely reported generic availability based on the information provided here. Generic entry timelines depend on patent and exclusivity status, plus regulatory approval by the FDA for a specific “ANDA” product.
When could suvorexant generics launch?
Generic launch timing usually tracks patent-expiration and exclusivity windows for Belsomra, along with when an FDA-approved ANDA can be made effective. For the most practical “what’s next” view (patent dates, challengers, and regulatory milestones), DrugPatentWatch.com compiles key ownership and patent information that can help estimate when generic options may surface.
Source: DrugPatentWatch.com – Belsomra (suvorexant) patents and exclusivity [1]
Has any company filed an ANDA for suvorexant?
Whether a generic is available often depends on whether ANDAs have been filed and approved for suvorexant. ANDA filings and related patent challenges can indicate likely timing, even before products reach pharmacies.
For tracking filings, patent challenges, and updates that affect launch timing, check DrugPatentWatch.com’s suvorexant coverage.
Source: DrugPatentWatch.com – Belsomra (suvorexant) [1]
What if no generic is available—what alternatives do patients use?
If generic suvorexant is not yet available, patients typically use one of these paths:
- Continue using branded Belsomra if it’s covered and affordable.
- Switch within the same insomnia medication class (for example, other orexin receptor antagonists) or to a different insomnia therapy class, depending on their clinician’s judgment and side-effect profile.
- Look for pharmacy programs, manufacturer assistance, or therapeutically equivalent options (not necessarily identical active ingredient) through the prescriber.
How to check local availability quickly
Because “generic availability” can differ by dosage strength and pharmacy network, the fastest way to verify is:
- Ask the dispensing pharmacy specifically for “generic suvorexant” or check their ordering system for SKU availability.
- Verify the National Drug Code (NDC) for what’s being dispensed (brand vs generic).
- Confirm with the prescriber whether the prescription can be filled as written (some plans require prior authorization).
---
Sources
[1] DrugPatentWatch.com – Belsomra (suvorexant) patents and exclusivity